Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia

BMC Pediatrics

Volumn 10, Issue , 2010, Pages

  Youn, You Sook ^a   Lee, Kyung Yil ^a   Hwang, Ja Young ^a   Rhim, Jung Woo ^a   Kang, Jin Han ^a   Lee, Joon Sung ^a   Kim, Ji Chang ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; C REACTIVE PROTEIN; BACTERIUM ANTIBODY;

ANTIBODY TITER; ARTICLE; BRONCHOPNEUMONIA; CHILD; CLINICAL FEATURE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FEVER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; LUNG LOBE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA; PRESCHOOL CHILD; SEROLOGY; THROMBOCYTOSIS; ADOLESCENT; AGE; AGGLUTINATION TEST; BLOOD; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MYCOPLASMA PNEUMONIA; PATHOLOGY;

ADOLESCENT; AGE FACTORS; AGGLUTINATION TESTS; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA;

EID: 77954198197     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-10-48     Document Type: Article

References (29)

1. Waites KB, Talkington DE. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004, 17:697-728. 10.1128/CMR.17.4.697-728.2004, 523564, 15489344.
2. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken GH. Eidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004, 113:701-707. 10.1542/peds.113.4.701, 15060215.
3. Principi N, Esposito S, Blasi F, Allegra L. Role of Mycoplasma pneumoniae and Clamidia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001, 32:1281-1289. 10.1086/319981, 11303262.
4. Othman N, Isaacs D, Kesson A. Mycoplasma pneumoniae infections in Australian children. J Paediatr Child Health 2005, 41:671-676. 10.1111/j.1440-1754.2005.00757.x, 16398873.
5. Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, Cirillo D, Di Pietro P, Rossi GA. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Resp Med 2008, 102:1762-1768.
6. Kim JW, Seo HK, Yoo EG, Park SJ, Yoon SH, Jung HY. Mycoplasa pneumoniae pneumonia in Korean children, from 1979 to 2006: a meta analysis. Korean J Pediatr 2009, 52:315-323.
7. Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. West J Med 995 162:133-142.
8. Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther 2008, 6:509-521. 10.1586/14787210.6.4.509, 18662117.
9. Sabato AR, Cooper DM, Thong YH. Transitory depression of immune function following Mycoplasma pneumoniae infection in children. Pediatr Res 1981, 15:813-816.
10. Radisic M, Torn A, Gutierrez P, Defranchi HA, Pardo P. Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clin Infect Dis 2000, 31:1507-1511. 10.1086/317498, 11096025.
11. Miyashita N, Obase Y, Ouchi K, Kawasaki K, Kawai Y, Kobayashi Y, Oka M. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol 2007, 56:1625-1629. 10.1099/jmm.0.47119-0, 18033831.
12. Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, Lee BC. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 2006, 41:263-268. 10.1002/ppul.20374, 16437541.
13. Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect 2008, 57:223-228. 10.1016/j.jinf.2008.06.012, 18656264.
14. Glader B. The anemias. Nelson Textbook of Pediatrics 2007, 2003. Philadelphia: WB Saunders Co, Behrman RE, Kliegman RM, Jenson HB, Stanton BF, 18.
15. Tanaka H, Koba H, Honma S, Sugaya F, Abe S. Relationships between radiological pattern and cell mediated immune response in Mycoplasma pneumoniae pneumonia. Eur Respir 1996, 9:669-672.
16. Klement E, Talkington DF, Wasserzug O, Kayouf R, Davidovitch N, Dumke R, Bar-Zeev Y, Ron M, Boxman J, Lanier Tracker W, Wolf D, Lazaovich T, Shemer-Avni Y, Glikman D, Jacobs E, Grotto I, Block C, Nir-Paz R. Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin Infect Dis 2006, 43:1239-1245. 10.1086/508458, 17051486.
17. Beersma MF, Dirven K, van Dam AP, Templeton KE, Claas EC, Goossens H. Evaluation of 12 commercial tests and the complementary fixation test for Mycoplasma pneumoniae-specific imunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J Clin Microbiol 2005, 43:2277-2285. 10.1128/JCM.43.5.2277-2285.2005, 1153783, 15872256.
18. Ozaki T, Nishimura N, Ahn J, Watanabe N, Muto T, Saito A, Koyama N, Nakane K, Funahashi K. Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children and the antimicrobial susceptibility of the isolates. J Infect Chemother 2007, 13:204-207. 10.1007/s10156-007-0519-6, 17721681.
19. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Tang BS, Hon TY, Chan KH, Ng WL, Lai RW, Guan Y, Yuen KY, . HKU/UCH SARS Study Group Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003, 361:1767-1772. 10.1016/S0140-6736(03)13412-5, 12781535, HKU/UCH SARS Study Group.
20. Lee KY, Lee HS, Hur JK, Kang JH, Lee BC. The changing epidemiology of hospitalized pediatric patients in three measles outbreaks. J Infect 2007, 54:167-172. 10.1016/j.jinf.2006.02.016, 16620998.
21. Dorigo-Zetsma JW, Wilbrink B, van der Nat H, Bartelds AI, Heijnen ML, Dankert J. Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis 2001, 183:675-678. 10.1086/318529, 11170998.
22. Yu J, Yoo Y, Kim DK, Kang H, Koh YY. Distributions of antibody titers to Mycoplasma pneumoniae in Korean children in 2000-2003. J Korean Med Sci 2005, 20:542-547. 10.3346/jkms.2005.20.4.542, 2782145, 16100441.
23. Cunha BA. The clinical diagnosis of Mycoplasma pneumoniae: the diagnostic importance of highly elevated serum cold agglutinins. Eur J Clin Microbiol Infect Dis 2008, 27:1017-1019. 10.1007/s10096-008-0526-2, 18592280.
24. Ngiam TE, Yap HK, Low PS, Vellayappan K, Wee PH. A rapid screening test in Mycoplasma pneumoniae infection. J Singapore Pediatr Soc 1980, 22:81-83.
25. Shankar EM, Kumarasamy N, Balakrishnan P, Solomon S, Lejith R, Vengatesan A, Anabd Rao U. Seroprevalence of acute Mycoplasma pneumoniae infection HIV infected patients with pulmonary complaints in Chennai, Southern India. J Infect 2006, 53:325-330. 10.1016/j.jinf.2005.11.184, 16442630.
26. Morozumi M, Ito A, Murayama SY, Hasegawa K, Kobayashi R, Iwata S, Kawamura N, Kuroki H, Nakayama E, Tajima T, Ubukata K. Assessment of real-time PCR for diagnosis of Mycoplasma pneumoniae pneumonia in pediatric patients. Can J Microbil 2006, 52:125-129.
27. Hamano-Hasegawa K, Morozumi M, Nakayama E, Iwata S, Sunakawa K, Ubukata K, . Acute Respiratory Diseases Study Group Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia. J Infect Chemother 2008, 14:424-432. 10.1007/s10156-008-0648-6, 19089556, Acute Respiratory Diseases Study Group.
28. Korppi M. Mixed microbial aetiology of community-acquired pneumonia in children. APMIS 2002, 110:515-522. 10.1034/j.1600-0463.2002.11007801.x, 12390408.
29. Tagliabue C, Salvatore CM, Techasaensiri C, Mejias A, Torres JP, Katz K, Gomez AM, Esposito S, Principi N, Hardy RD. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. J Infect Dis 2008, 198:1180-1188. 10.1086/591915, 2562003, 18717637.